Bogart Wealth LLC increased its position in shares of iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report) by 14.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,425 shares of the company’s stock after buying an additional 828 shares during the quarter. Bogart Wealth LLC’s holdings in iShares iBonds Dec 2027 Term Corporate ETF were worth $157,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. GAMMA Investing LLC grew its holdings in shares of iShares iBonds Dec 2027 Term Corporate ETF by 96.0% during the 2nd quarter. GAMMA Investing LLC now owns 44,625 shares of the company’s stock worth $1,059,000 after purchasing an additional 21,854 shares during the period. Exchange Capital Management Inc. boosted its stake in iShares iBonds Dec 2027 Term Corporate ETF by 44.3% during the first quarter. Exchange Capital Management Inc. now owns 28,546 shares of the company’s stock worth $679,000 after buying an additional 8,759 shares during the period. Godshalk Welsh Capital Management Inc. increased its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 120.4% during the second quarter. Godshalk Welsh Capital Management Inc. now owns 25,349 shares of the company’s stock valued at $602,000 after acquiring an additional 13,849 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF by 26.7% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 96,048 shares of the company’s stock valued at $2,279,000 after acquiring an additional 20,234 shares during the period. Finally, InterOcean Capital Group LLC raised its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF by 16.1% in the 1st quarter. InterOcean Capital Group LLC now owns 31,071 shares of the company’s stock valued at $739,000 after acquiring an additional 4,318 shares during the period.
iShares iBonds Dec 2027 Term Corporate ETF Stock Up 0.1 %
NYSEARCA:IBDS opened at $24.13 on Friday. iShares iBonds Dec 2027 Term Corporate ETF has a fifty-two week low of $22.91 and a fifty-two week high of $24.68. The company has a 50 day moving average price of $24.25 and a 200 day moving average price of $23.92.
About iShares iBonds Dec 2027 Term Corporate ETF
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares iBonds Dec 2027 Term Corporate ETF
- Top Stocks Investing in 5G Technology
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What Are Dividend Achievers? An Introduction
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Election Stocks: How Elections Affect the Stock Market
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding IBDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report).
Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.